Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-(3-methylphenoxy)-2(1h)-pyrimidinone
2. Mlr-1023
1. 41964-07-2
2. Mlr-1023
3. Cp-26154
4. 5-(m-tolyloxy)pyrimidin-2(1h)-one
5. Mlr 1023
6. 5-(3-methylphenoxy)-2(1h)-pyrimidinone
7. 5-(3-methylphenoxy)-1h-pyrimidin-2-one
8. 2(1h)-pyrimidinone, 5-(3-methylphenoxy)-
9. Cp-26,154
10. Mlr-1003
11. Mu3jd8e9is
12. Nsc-314335
13. Tolimidone (usan)
14. Nsc 314335
15. Cp 26154
16. Tolimidone [usan]
17. Tolimidone [usan:inn]
18. Unii-mu3jd8e9is
19. Tolimidone [inn]
20. Chembl8030
21. Tolimidone (mlr-1023)
22. Tolimidone [who-dd]
23. Mls006012600
24. Schembl637505
25. Gtpl9433
26. Schembl21168610
27. Dtxsid50194786
28. Hms3749i15
29. Bcp06813
30. Ex-a1338
31. Bdbm50545405
32. Mfcd00866900
33. Nsc314335
34. S8321
35. Zinc17120697
36. 5-(m-tolyloxy)-2(1h)-pyrimidinone
37. Akos000282153
38. Ccg-266597
39. Cs-7936
40. Sb17288
41. Ncgc00370768-01
42. Ncgc00370768-04
43. As-16416
44. Hy-59047
45. Smr004704144
46. 5-(3-methylphenoxy)- 2(1h)-pyrimidinone
47. Mlr-1023, >=98% (hplc)
48. D06182
49. A899682
50. Q7814266
51. Cp 26154; Nsc 314335; 5-(3-methylphenoxy)-2(1h)-pyrimidinone;mlr 1023
| Molecular Weight | 202.21 g/mol |
|---|---|
| Molecular Formula | C11H10N2O2 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 202.074227566 g/mol |
| Monoisotopic Mass | 202.074227566 g/mol |
| Topological Polar Surface Area | 50.7 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 310 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tolimidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolimidone, including repackagers and relabelers. The FDA regulates Tolimidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolimidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tolimidone supplier is an individual or a company that provides Tolimidone active pharmaceutical ingredient (API) or Tolimidone finished formulations upon request. The Tolimidone suppliers may include Tolimidone API manufacturers, exporters, distributors and traders.
Tolimidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tolimidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tolimidone GMP manufacturer or Tolimidone GMP API supplier for your needs.
A Tolimidone CoA (Certificate of Analysis) is a formal document that attests to Tolimidone's compliance with Tolimidone specifications and serves as a tool for batch-level quality control.
Tolimidone CoA mostly includes findings from lab analyses of a specific batch. For each Tolimidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tolimidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolimidone EP), Tolimidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolimidone USP).
LOOKING FOR A SUPPLIER?
